Literature DB >> 11078877

Anomalous dystroglycan in carcinoma cell lines.

C Losasso1, F Di Tommaso, A Sgambato, R Ardito, A Cittadini, B Giardina, T C Petrucci, A Brancaccio.   

Abstract

Dystroglycan is a receptor responsible for crucial interactions between extracellular matrix and cytoplasmic space. We provide the first evidence that dystroglycan is truncated. In HC11 normal murine and the 184B5 non-tumorigenic mammary human cell lines, the expected beta-dystroglycan 43 kDa band was found but human breast T47D, BT549, MCF7, colon HT29, HCT116, SW620, prostate DU145 and cervical HeLa cancer cells expressed an anomalous approximately 31 kDa beta-dystroglycan band. alpha-Dystroglycan was udetectable in most of the cell lines in which beta-dystroglycan was found as a approximately 31 kDa species. An anomalous approximately 31 kDa beta-dystroglycan band was also observed in N-methyl-N-nitrosurea-induced primary rat mammary tumours. Reverse transcriptase polymerase chain reaction experiments confirmed the absence of alternative splicing events and/or expression of eventual dystroglycan isoforms. Using protein extraction procedures at low- and high-ionic strength, we demonstrated that both the 43 kDa and approximately 31 kDa beta-dystroglycan bands harbour their transmembrane segment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078877     DOI: 10.1016/s0014-5793(00)02157-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Dystroglycan expression in human placenta: basement membrane localization and subunit distribution change between the first and third trimester.

Authors:  Reagan M Street; Sara J Mucowski; Rheann Urrabaz-Garza; Kyle O'Boyle; Russell R Snyder; Regan N Theiler
Journal:  Reprod Sci       Date:  2011-12-02       Impact factor: 3.060

2.  Proliferative, structural and molecular features of the Mdx mouse prostate.

Authors:  Leslie C Pinto; Wagner J Fávaro; Valéria H A Cagnon
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

3.  Dystroglycan loss disrupts polarity and beta-casein induction in mammary epithelial cells by perturbing laminin anchoring.

Authors:  M Lynn Weir; Maria Luisa Oppizzi; Michael D Henry; Akiko Onishi; Kevin P Campbell; Mina J Bissell; John L Muschler
Journal:  J Cell Sci       Date:  2006-09-12       Impact factor: 5.285

4.  Reduction of α-dystroglycan expression is correlated with poor prognosis in glioma.

Authors:  Xin Zhang; Xiang-Hui Dong; Yue Ma; Lan-Feng Li; He Wu; Min Zhou; Yun-He Gu; Guo-Zhong Li; De-Sheng Wang; Xiao-Feng Zhang; Jing Mou; Ji-Ping Qi
Journal:  Tumour Biol       Date:  2014-08-20

5.  Dystroglycan receptor is involved in integrin activation in intestinal epithelia.

Authors:  Adel Driss; Laetitia Charrier; Yutao Yan; Vivienne Nduati; Shanthi Sitaraman; Didier Merlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-12-15       Impact factor: 4.052

6.  Mice lacking dystrophin or alpha sarcoglycan spontaneously develop embryonal rhabdomyosarcoma with cancer-associated p53 mutations and alternatively spliced or mutant Mdm2 transcripts.

Authors:  Karen Fernandez; Yelda Serinagaoglu; Sue Hammond; Laura T Martin; Paul T Martin
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

7.  Dystroglycan versatility in cell adhesion: a tale of multiple motifs.

Authors:  Chris J Moore; Steve J Winder
Journal:  Cell Commun Signal       Date:  2010-02-17       Impact factor: 5.712

8.  Formation of multiple complexes between beta-dystroglycan and dystrophin family products.

Authors:  M Royuela; D Chazalette; G Hugon; R Paniagua; V Guerlavais; J A Fehrentz; J Martinez; J P Labbe; F Rivier; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

9.  Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts.

Authors:  Fei Wang; Rhonda K Hansen; Derek Radisky; Toshiyuki Yoneda; Mary Helen Barcellos-Hoff; Ole W Petersen; Eva A Turley; Mina J Bissell
Journal:  J Natl Cancer Inst       Date:  2002-10-02       Impact factor: 13.506

10.  Dystroglycan and perlecan provide a basal cue required for epithelial polarity during energetic stress.

Authors:  Vincent Mirouse; Christina P Christoforou; Cornelia Fritsch; Daniel St Johnston; Robert P Ray
Journal:  Dev Cell       Date:  2009-01       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.